Results 1 to 10 of about 2,529,224 (293)

Clinical Applicability of Tissue Polypeptide Antigen and CA-125 in Gynecological Malignancies

Biomedicines, 2023
Background: Nowadays there still is no sufficient screening tool for ovarian and uterine cancer. Objective: The current study aimed to investigate whether cancer antigen 125 (CA-125), tissue polypeptide antigen (TPA) or the combination of both markers ...
Lars Schröder, Christian M. Domroese, Alexander B. A. Rupp, Kathrin M. E. Gihr, Christoph Niederau, Michael R. Mallmann, Stefan Holdenrieder   +6 more
doaj   +4 more sources

Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure

Diagnostics
Background: Heart failure is a global major healthcare problem with millions of hospitalizations annually and with a very high mortality. There is an increased interest in finding new and reliable biomarkers for the diagnostic, prognostic and therapeutic
Mihai Cristian Marinescu, Violeta Diana Oprea, Sorina Nicoleta Munteanu, Aurel Nechita, Dana Tutunaru, Luiza Camelia Nechita, Aurelia Romila   +6 more
doaj   +4 more sources

Karakteristik Karsinoma Ovarium Pra-Menopause dengan Kadar CA 125 ≤200 U/mL di RSUP Dr. Hasan Sadikin Bandung dari Tahun 2019–2021

Obgynia, 2023
Tujuan: Mendeskripsikan karakteristik karsinoma ovarium pra-menopause dengan kadar CA 125 ≤ 200 U/mL di RSUP Dr. Hasan Sadikin Bandung dari tahun 2019 sampai 2021.
Yudi Mulyana Hidayat, Eunike Febe Febriani, Ali Budi Harsono, Gatot N. A. Winarno, Andi Kurniadi   +4 more
doaj   +1 more source

CA-19-9 as an Emerging Marker of Ovarian Tumour: A Rare Entity [PDF]

Journal of Clinical and Diagnostic Research, 2019
Tumour markers are widely used in clinical practice for diagnosis; follow-up, prognosis and to predict recurrence of certain malignancies. Markers for ovarian cancer include CA-125 antigen, CA-15-3 antigen, and Carcino-Embryonic Antigen (CEA).
Alpana Singh, Astha Srivastava, Divya Chauhan, Rajeshwari Gautam, Gita Radhakrishnan   +4 more
doaj   +1 more source

Assessment of carcinoembryonic antigen as a prognostic marker in ovarian malignancies treated in a rural hospital of West Bengal

Asian Journal of Medical Sciences, 2022
Background: Ovarian neoplasms are the second most common cause of gynecological malignancy both worldwide as well as in India. Innocuous clinical presentation and late diagnosis contribute to the mortality toll of this neoplasm.
Phalguni Chakrabarti , Krishnendu Layek , Debasmita Bandyopadhyay, Sanghamitra Chakraborty , Ayesha Hasan , Pinaki Sarkar   +5 more
doaj   +1 more source

Clinical risk factors of carbohydrate antigen-125, cytokeratin fragment 19, and neuron-specific enolase in liver metastases from elderly lung cancer patients

Frontiers in Genetics, 2022
Objective: Lung cancer is a common malignant tumor characterized by challenging detection and lack of specificity in clinical manifestations. To investigate the correlation of tumor markers in the serum with liver metastasis and prognosis of lung cancer ...
Tao Cheng, Jun Chen, Ping Ying, Hong Wei, Huiye Shu, Min Kang, Jie Zou, Qian Ling, Xulin Liao, Yixin Wang, Yi Shao   +10 more
doaj   +1 more source

The Diagnostic Value of carcinoembryonic Antigen and cancer Antigen 125 in Malignant Pleural Effusion [PDF]

Zagazig University Medical Journal
Many studies have proved that carcinoembryonic antigen (CEA) and cancer antigen 125 (CA125) have high affinity and binding specificity, and can be used to distinguish pleural effusion in patients with malignant and non-malignant pleural effusion.
Adel Elghamrawy, Mohamed Naguib, Hanan Abd Duw, Niveen zayed   +3 more
doaj   +1 more source

Immunoradiometric assay of CA 125 in effusions comparison with carcinoembryonic antigen [PDF]

Cancer, 1987
The levels of CA 125 antigen were measured in 167 effusions from 150 patients using radioimmunoassay, and the results compared with the levels of carcinoembryonic antigen (CEA) in the fluids. This study was carried out to test a hypothesis that measuring the combined levels of selected tumor associated antigens in effusions could predict the primary ...
M M, Pinto, L H, Bernstein, D A, Brogan, E, Criscuolo   +3 more
openaire   +2 more sources

Comparison of seven immunoassays for the quantification of CA 125 antigen in serum [PDF]

Clinical Chemistry, 1998
Abstract Seven CA 125 immunoassays were compared for their clinical performance. CA 125 concentrations were determined in 289 serum samples obtained from women with benign pelvic tumors (samples from 98 patients) and patients with various cancers (samples from 111 patients).
E M, Davelaar, G J, van Kamp, R A, Verstraeten, P, Kenemans   +3 more
openaire   +2 more sources

Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression

Journal of Evidence-Based Integrative Medicine, 2023
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors.
Abd AlRahman Mohammad Foda MD, Tarek Atia MD, Hader I. Sakr MD, Khaled Abd Elaziz Ahmed Elnaghi MD, Wagih M. Abdelhay MD, Eman T. Enan MD   +5 more
doaj   +1 more source